European Gas Is Up 129% in a Year. Here Is Who Pays and Who Profits.
The Hormuz-driven surge in TTF prices near €74/MWh is quietly reshaping the winners and losers inside your portfolio.
Oil Hits $90 Again. Occidental Is the Stock Built for This Moment.
WTI crude surged 5% Tuesday on fresh Iran strikes near the Strait of Hormuz. OXY just posted record free cash flow and cut debt to a seven-year low. The math at $90 oil is compelling.
Salesforce’s Valuation Gap Is the Opportunity
Agentforce logged 3.2 billion Agentic Work Units in one quarter. The stock still prices in deep skepticism.
Amazon’s Ad Machine Is Now the Target. What a $20 Billion Case Costs.
The FTC and 22 state AGs say Amazon inflated ad-auction prices starting in 2018. The Prime settlement tells investors roughly what that kind of case is worth.
The S&P 500 Enters September With a Fed Decision and $91 Oil
After a positive August and a 13.1% year-to-date gain, history says September can still be positive. The real threats are three events inside the next 16 sessions.
Buy, Rent, or Invest? Home Prices and a 4.75% Ten-Year
Mortgage rates near 6.9% and rents rising fastest in over a year are shifting the rent-versus-own math.
The RTO Compliance Trap: Headcount Is the Wrong Metric
Full-time mandates are producing bodies in chairs, not measurable gains, and the data on who leaves first is the number executives should be watching.
What Last Year’s Shutdown Tells You About This One
The October 2025 shutdown erased a jobs report and barely dented the S&P 500. Here is the calm playbook if history repeats.
Myqorzo’s Balance Sheet Meets Its Biggest Catalyst
With $1.7B in cash and a Q4 sNDA plan, Cytokinetics just validated a major untreated corner of HCM.
MCK Already Compounds. This Deal Speeds It Up.
McKesson’s $2.25bn Precision deal adds clinical research heft to its fast-growing oncology segment.